A warning has been issued by the Food and Drug Administration (FDA) against pharmaceutical companies making false claims that nasal spray products work as Covid19 treatment or prevention.
FDA chief Eric Domingo is quick to clarify that there are many nasal spray products with authorization for market sales “but none of those products are registered with the FDA for Covid19.” He said the agency will be looking into reports that nasal sprays are being used for Covid19 treatment.
An advisory dated September 10 by the agency referred to nasal sprays currently sold in the market as “medical devices, which are intended for short-term use in the nasal cavity and serve as mechanical barriers from particulates.”
They noted that the products “coat the nasal mucosa with substances that have no specific effect against pathogens.”
Moreover, the agency warned the public explicitly that nasal sprays are not-and should not-be used as medicine or vaccine substitutions in Covid19 treatment.
FDA Center for Device Regulation, Radiation Health and Research director Cecille Matienzo said they are already diving into registered nasal spray products in their database. “From there we can see which will be part of the review. We cannot say at this time if it is purely misleading claims or on the marketing of the products.”
The Philippine Society of Otolaryngology has also spoken up to support the FDA’s take on nasal sprays not being Covid19 treatment or prevention.
According to the Department of Trade and Industry, companies marketing nasal sprays as Covid19 treatment could face charges.